THEMISMED132.00

Themis Medicare Limited

· Pharma & Health
₹ CrorePeersLINCOLNBAJAJHCARESIGACHIWANBURYAMRUTANJANAHCLANUHPHRMcap ₹1,216 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)304.22403.29516.49516.49
Receivable Days (DSO)170.13159.41189.96189.96
Payable Days (DPO)203.86246.04323.80296.84
Cash Conversion Cycle (days)270.49316.66382.65409.61
Working Capital Turnover2.752.742.472.39
Asset Turnover0.670.690.570.57
Cash Conversion (CFO/Net Income)0.331.16-2.86-2.86
CFO/EBITDA0.280.71-8.30-8.30
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.